Novel treatment targets BTK through multi-immune modulation to help address the underlying causes of ITP Approval based on the LUNA 3 phase 3 study that demonstrated rapid and durable platelet ...

InnoCare Pharma’s orelabrutinib is progressing to a pivotal trial in systemic lupus erythematosus (SLE) after the drug displayed encouraging activity in a mid-stage trial. During the Phase IIb study ...

American beverage manufacture Anheuser-Busch has announced its acquisition of a majority stake in BeatBox, a rapidly growing player in the alcoholic ready-to-drink (RTD) beverage sector. This deal ...

Anheuser-Busch InBev is to acquire a majority stake in BeatBox, the US-based hard-punch maker. The Leffe beer maker will pay up to around $490m for an 85% shareholding in BeatBox. The deal also offers ...

One of the most anticipated deals in the beverage industry is now official: Anheuser-Busch InBev has acquired a majority stake of Austin booze brand BeatBox for $490 million. AB InBev announced the ...

Dec 5 (Reuters) - Anheuser-Busch InBev (ABI.BR), opens new tab on Friday said it plans to acquire a majority stake in the U.S.-based ready-to-drink beverage brand BeatBox for about $490 million. The ...

Austin-based alcoholic drink brand BeatBox has sold a majority stake to Anheuser-Busch, in a deal that includes a path to full ownership in the future. In the $490 million deal, Anheuser-Busch InBev — ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Austin-based BeatBox is set to ...

With both a label expansion and a conversion to a full approval, Eli Lilly has earned the FDA’s go-ahead to act on the initial promise it saw with its BTK inhibitor Jaypirca (pirtobrutinib). Just ...

Anticipating the 2025 American Society of Hematology Annual Meeting and Exposition, Suchitra Sundaram, MD, reviews several clinical trials in chronic lymphocytic leukemia (CLL) that will present data ...

Global brewing giant Anheuser-Busch InBev is reportedly close to buying US-based hard-punch maker BeatBox Beverages. The Leffe beer maker is in talks to snap up the RTD brand, people familiar with the ...

A drug-eluting resorbable scaffold continues to keep many patients with below-the-knee (BTK) chronic limb-threatening ischemia (CLTI) free from repeat procedures, even after most of the device’s ...